The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Tracking tumor-specific mutations in circulating-free DNA to predict early relapse after treatment of primary breast cancer.
Nicholas C. Turner
No relevant relationships to disclose
Isaac Garcia-Murillas
No relevant relationships to disclose
Gaia Schiavon
No relevant relationships to disclose
Sarah Hrebien
No relevant relationships to disclose
Peter Osin
No relevant relationships to disclose
Ashutosh Nerurkar
No relevant relationships to disclose
Iwanka Kozarewa
No relevant relationships to disclose
Javier Armisen Garrido
No relevant relationships to disclose
Mitchell Dowsett
No relevant relationships to disclose
Ian E. Smith
No relevant relationships to disclose